Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why the USPTO will not review the 584: new rules will not allow them too
3
Nov 12, 2007 05:31AM

Nov 12, 2007 06:16AM

Nov 12, 2007 07:00AM
1
Nov 12, 2007 07:01AM

NEW USPTO rules  do not allow them to review applications > 25 claims

On resubmission TPL/Moore et al amended the application and added another 40 or so claims.

Ergo patent office will not review,

 Was this a devious stratgey or a favorable coincedence.  Anyway while the USPTO has reexam on hold TPL files appeal.

If they win on appeal then no reason to add more claims

This is the stuff they write textbooks about it's wonderful intrigue I'm lovin it.

1
Nov 12, 2007 09:20AM
Share
New Message
Please login to post a reply